Market
First cancer type to receive AI-designed mRNA vaccine approval by end of 2025?
3
Resolution / Starting Odds
Breast Cancer • 25%
Lung Cancer • 25%
Prostate Cancer • 25%
Other • 25%
FDA announcements or credible news reports
Story
Oracle CEO Larry Ellison Announces AI-Designed mRNA Cancer Vaccines in 48 Hours, Enabling Early Detection and Personalized Therapies
Jan 21, 2025, 11:05 PM
Oracle CEO Larry Ellison announced at the White House that artificial intelligence (AI) will soon be capable of designing personalized mRNA vaccines for individuals to combat cancer, with the potential for development within 48 hours. During the announcement, Ellison emphasized the dual capabilities of AI: early detection of cancer and the creation of tailored vaccine therapies. He described this initiative as one of the most exciting projects Oracle is working on, highlighting the promise of AI in revolutionizing healthcare. Ellison's vision includes using AI to conduct blood tests for early cancer detection, followed by gene sequencing of tumors to enable personalized vaccination. This approach aims to redefine cancer treatment and accelerate the path to cures.
View original story
Similar markets
Other • 25%
Lung Cancer • 25%
Breast Cancer • 25%
Prostate Cancer • 25%
United States • 25%
United Kingdom • 25%
Other • 25%
Germany • 25%
Oracle • 25%
Pfizer • 25%
Moderna • 25%
Other • 25%
Kidney Cancer • 25%
Melanoma • 25%
Lung Cancer • 25%
Gastrointestinal Cancer • 25%
China • 25%
Other • 25%
EU • 25%
USA • 25%
Other • 25%
Lung Cancer • 25%
Breast Cancer • 25%
Colon Cancer • 25%
BioNTech • 25%
Moderna • 25%
Oracle • 25%
Other • 25%
Other types • 25%
Prostate cancer • 25%
Lung cancer • 25%
Breast cancer • 25%
No • 50%
Yes • 50%
Other • 25%
United Kingdom • 25%
Germany • 25%
United States • 25%
